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Abstract
Elevated blood pressure is a condition in which systolic blood pressure is 120-129 mmHg
and diastolic blood pressure is less than 80 mmHg, according to the CDC (2020), which
points out that elevated blood pressure often leads to hypertension. In 2017, The
American Heart Association (AHA) released guidelines to aid providers in the early
detection and management of hypertension. These guidelines integrate
nonpharmacological and pharmacological therapies. The nonpharmacological therapies
include following a heart-healthy diet, weight loss, sodium restriction, limitation of
alcohol and tobacco consumption, and increased physical activity (AHA, 2018).
Hypertension, “the silent killer” is one of the major causes of premature death (WHO,
2019). The review of literature indicates the importance of lifestyle changes for treatment
(Doubova et al., 2016). However, primary care providers are reluctant to diagnose
younger patients with high blood pressure (Johnson, 2017). The purpose of this study was
to determine if primary care provides are treating patients 18 years old or older with
elevated blood pressure per the AHA’s 2017 guidelines. The data collected could bring
awareness to the 2017 AHA Hypertension guidelines and promote the adherence of these
guidelines by primary care providers in reducing elevated blood pressure and preventing
hypertension.

9
Table of Contents
CHAPTER 1: DIMENSIONS OF THE PROBLEM
Problem Statement ................................................................................... 13
Statement of Purpose ............................................................................... 14
Significance of the Study ......................................................................... 15
Theoretical Foundation ............................................................................ 17
Research Questions .................................................................................. 18
Definitions of Terms ................................................................................ 18
Primary Care Providers (PCP) ................................................................. 18
Theoretical ............................................... 19
Operational ............................................... 19
Follow-up ................................................................................................. 19
Theoretical ................................................. 19
Operational ................................................. 19
Patient (s) ................................................................................................. 19
Theoretical .................................................. 19
Operational .................................................. 19

10
Elevated Blood Pressure .......................................................................... 19
Theoretical ................................................... 19
Operational ................................................... 19
Educate ..................................................................................................... 19
Theoretical ..................................................... 19
Operational ..................................................... 20
Nonpharmacologic therapy ...................................................................... 20
Theoretical ...................................................... 20
Operational ...................................................... 20
Assumptions ..................................................................................................................... 20
Limitations ....................................................................................................................... 20
Summary .......................................................................................................................... 21
CHAPTER II: REVIEW OF LITERATURE
An Overview of the Literature Regarding Hypertension .................................... 22
Conceptual Framework ……………………....................................................... 22
Review of Related Research ………………….…………………………..…… 23
Impact of the Problem ………………………………………………………… 27

11
Utilization of the Guidelines …………………………………….………..…… 29
Barriers ………………………………………………………….…………...… 39
CHAPTER III: DESIGN AND METHODOLOGY
Design of the Study ……………………………………………….……………. 43
Setting for the Research Project ………………………….…………..………… 44
Population and Sample …………………………………………………..…….. 44
Methods of Data Collection ................................................................................. 44
Methods of Data Analysis .................................................................................... 45
CHAPTER IV: PRESENTATION OF FINDINGS
Results …………………………………………………………………….……. 46
Profile of Study Participants ……………………………..…………..………… 47
Age ……………………………………..……….. 47
Gender ………………………………….…….…. 47
Race ……………………………………………... 48
Provider Type ………………………………...…. 48
Payor Source ………………………………….…. 49
Elevated Blood Pressure ……………………….… 50

12
Nonpharmacological Treatment Documented ……. 50
Interventions Documented ……………….….……. 51
Statistical Results ………………………………………………………….…… 52
Summary ……………………………………………………………………….. 52
CHAPTER V: SUMMARY AND CONCLUSIONS
Implications …………………………………..……………..………………….. 53
Summary of the Findings ………………………………………………....……. 55
Discussion of the Findings ……………………………………..………….…… 56
Implications ……………………………………………………………..……… 62
Recommendations …………………………………………….…………..……. 63
Conclusions ……………………………………………………………..……… 64
REFERENCES .................................................................................................. 66
APPENDICES: ………………………………………………………………. 70
APPENDIX A: Data Collection Research Tool……….…… 70
APPENDIX B: IRB Approval letter ………………………. 72
APPENDIX C: Consent to conduct study…………………. 73

13
CHAPTER I: DIMENSIONS OF THE PROBLEM
Hypertension is a severe medical condition that affects people of all ages and races
worldwide. A record of two or more elevations in systolic blood pressure above 129 and
diastolic greater than 80, properly measured, is obtained before a diagnosis of
hypertension. Blood pressure can be classified as normal, elevated, stage one
hypertension, and stage two hypertension. Guidelines are in place to assist primary care
providers in making plans with patients for each stage. Primary care providers are on the
frontlines in terms of hypertension diagnoses, and are most likely to diagnose elevated
blood pressure and hypertension from regularly scheduled visits and sick visits with
patients.
More than one billion people around the world have a confirmed diagnosis of
hypertension (WHO, 2019). These statistics are staggering, especially considering that
there are likely substantially more cases which go undiagnosed. Because of this,
hypertension has earned the name “the silent killer;” a shocking number of premature
deaths occur each year due to the disease, whether it be diagnosed or not (WHO, 2019).
Many people are unaware they even have this condition until they begin to exhibit signs
and symptoms of irreversible target organ damage. In the United States, 1 out of 2 adults
have hypertension (Million Hearts, 2020).
According to the Mississippi Department of Health, more than 700,000 adults
have a diagnosis of hypertension (2019). The rates of hypertension in Mississippi are
among the top in the country, placing patients at an increased risk of heart disease and
stroke. Strokes are among the top five leading causes of death in the United States (CDC,
2019). The CDC also points out that stroke is also known to be the leading cause of
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severe long-term disability in adults. This is an alarming statistic because approximately
80% of strokes are preventable (2019). Hypertension also impacts the United States
economy. On average, from 2003 through 2014, hypertension cost the United States
approximately $131 billion (CDC, 2020b).
In 2017, The American Heart Association (AHA) released guidelines to aid
providers in the early detection and management of hypertension, which integrate
nonpharmacological and pharmacological therapies. The nonpharmacological therapies
that can be utilized to prevent hypertension include following a heart-healthy diet, weight
loss, sodium restriction, limitation of alcohol and tobacco consumption, and increased
physical activity (2018). These are also factors that can be modified to reduce the risk of
strokes, with the addition of adequately managing elevated blood pressures. Early
recognition and intervention are critical to the prevention of hypertension and subsequent
stroke. Uncontrolled hypertension is a significant health risk that, if not properly
managed, can lead to multi-system organ damage and leave a lasting impact on a
patient’s health. Overall, this was the AHA’s goal in revising such guidelines so that
early detection would be more possible for patients who exhibit early signs of risk in
developing hypertension.
Purpose of the Research
The purpose of this study is to determine if primary care providers are
implementing the guidelines set forth by the AHA regarding interventions to prevent,
detect, and treat hypertension. The primary focus is on patients without a diagnosis of
hypertension. By following the guidelines, primary care providers can intervene early
when a patient has elevated blood pressure. Patients have the opportunity to be educated
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on nonpharmacological interventions listed in the guidelines to modify their diet and
lifestyle to reduce their risk of progressing to a hypertension diagnosis. The guidelines
state that if a patient has an elevated blood pressure reading, primary care providers
should educate on nonpharmacological therapies and re-evaluate in three to six months.
Significance of the Research
According to the 2017 AHA Hypertension Guidelines, hypertension diagnosis is
now divided into elevated blood pressure, hypertension stage 1, and hypertension stage 2.
Elevated blood pressure is systolic blood pressure (SBP) 120-129 mmHg and diastolic
blood pressure (DBP) less than 80 mmHg. Hypertension stage 1 is defined as SBP 130139 mm Hg or DBP 80-89 mm Hg. Hypertension stage 2 as SBP equal to or greater than
140 mm Hg and DBP equal to or greater than 90 mm Hg. These guidelines are specific
and lower than previous guidelines used to diagnose hypertension in order to allow for
better chances at early detection and prevention meausres (AHA, n.d.). More than 108
million adults in the U.S. have hypertension, which amounts to roughly half of all adults;
of those adults, only one-fourth have controlled hypertension (CDC, 2020b). In
Mississippi alone, over 700,000 people live with hypertension (MSDH, 2020).
Hypertension, if not controlled, is one of the leading causes of stroke. There have
been studies that show if hypertension is controlled early or if elevated blood pressure is
managed and never advances to hypertension, the risk of a cardiovascular event would be
significantly reduced (Yano, et al., 2018). Consequently, this study of providers’
compliance with the 2017 AHA Hypertension Guidelines in respect to elevated blood
pressure holds magnitude for nursing practice as well as nursing research, nursing
education, and nursing theory.
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The current study will be significant to primary care providers as well as nursing
practice in determining if patients with elevated blood pressure are being monitored,
educated, and followed up with as recommended by the 2017 AHA Hypertension
Guidelines. If the study’s findings show that patients with elevated blood pressure are
being treated according to the guidelines, the clinics where the research was conducted
can be analyzed to help other clinics that struggle with following guidelines. If patients
with elevated blood pressure are not being monitored, educated, and followed up with as
recommended by the 2017 AHA Hypertension Guidelines, this study will indicate that
education is critical for the clinics utilized in this study as well as other primary care
clinics, providers, and nurses in similar areas.
Pender’s Health Promotion Model (HPM) was used for this study as education
about health promotion activities can give the patient the autonomy to make health
decisions based on perceived benefits (Sakraida & Wilson, 2017). The HPM emphasizes
that patients' adherence to health-promoting behaviors is based on their perceived
benefits. If the patient understands the complications of uncontrolled blood pressure, he
or she will be more inclined to adhere to nonpharmacologic treatment of elevated blood
pressure. The primary care providers would also benefit from the knowledge and use of
the HPM. If the primary care providers applied the HMP theory to their own practices,
the management of elevated blood pressure would be ingrained in the care provided.
The study’s findings may impact clinics and primary care providers' education
given to patients with use of the 2017 AHA Hypertension Guidelines to monitor, educate,
and follow up with elevated blood pressure patients. The findings could also recommend
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to other researchers what areas of elevated blood pressure management should be further
investigated.
Conceptual Framework
Nola Pender’s Health Promotion Model is a theory that emphasizes different factors
which affect a patient’s health-promoting activities. These factors in a patient’s life
would either promote health or prevent the patient from achieving health. The Health
Promotion Model (HPM) was initially introduced in 1982 and has grown significantly in
managing chronic health conditions. Health promotion, when managing a health
condition, has increased importance because of the individual benefit but also the benefit
to society as a whole (Sakraida & Wilson, 2017, p. 329).
Factors that influence a patient’s health-promoting activities are described by the
HPM. Personal Factors of the patient are described as being either biological,
psychological, and/or sociocultural and can influence behavior. The patient’s perceived
benefits are ideas that a patient would have regarding positive outcomes influenced by
performing a health-promoting activity such as exercising to reduce weight. Whereas, the
patient’s perceived barriers are the patient’s perceived obstacles to performing a healthpromoting activity such as cost or time. For example, a perceived obstacle to eating
healthy is that it is often more expensive. Patients also have perceived self-efficacy,
which is their beliefs in their own abilities to perform such health-promoting activities.
Activity-related effect refers to the feelings a patient experiences during, before, or after a
health-promoting activity. The activity-related effect could be positive or negative based
on the patient’s experience. Interpersonal influences are family, friends, healthcare
providers, and other people who have an influence on the patient’s life (Sakraida &
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Wilson, 2017, p. 326). Interpersonal influences are essential to the current study because
of the provider's ability to educate and promote non-pharmacological measures to the
patient, therefore affecting health outcomes.
The present study was a retrospective chart review conducted in Mississippi clinics
to determine if primary care providers are addressing elevated blood pressure per the
2017 AHA Hypertension Guidelines. The HPM was chosen to guide the research because
the model’s core is facilitating health promotion. Using the HPM, the researchers could
infer the power of the primary care provider as a positive influence on the patient’s health
and behaviors.
Research Questions and Hypotheses
Two research questions were formed to help guide data collection regarding
primary care providers' implementation of 2017 AHA Hypertension Guidelines. The two
questions are as follows:
1. Are primary care providers following up within 3-6 months with patients who
have elevated blood pressure per 2017 AHA Hypertension Guidelines?
2. Are primary care providers educating patients on nonpharmacological therapies
whose blood pressure is found to be elevated?
Definition of Terms
For this study, several terms were defined as they apply. The theoretical and operational
definitions follow, respectively.
Primary care providers (PCP)
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Theoretical. The healthcare provider (i.e., the nurse practitioner, physician's
assistant, or physician) to whom a patient first goes to address a problem with his or her
health (Venes, 2013).
Operational. A nurse practitioner, physician's assistant, or a physician who
manages chronic conditions in a clinical setting that is utilized for the current study.
Follow-up
Theoretical. The continued care or monitoring of a patient after the initial visit or
examination (Venes, 2013).
Operational. A three to six month follow up appointment was documented by the
provider to further evaluate the ongoing elevated blood pressure according to the 2017
AHA Hypertension Guidelines.
Patient (s)
Theoretical. One who is sick with or being treated for an illness or injury (Venes,
2013).
Operational. An individual that is 18 years or older with elevated blood pressure
and no previous diagnosis of hypertension.
Elevated blood pressure
Theoretical. Blood pressure readings consistently range from 120-129 systolic
and Less than 80 mm Hg diastolic (2018).
Operational. A systolic BP reading of 120-129 mm Hg and a diastolic BP reading
less than 80mm Hg as documented in the medical record.
Educate
Theoretical. Imparting, receiving, or acquiring knowledge (Venes, 2013).
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Operational. Written documentation in the patient’s plan of care regarding
nonpharmacological treatments of elevated blood pressure.
Nonpharmacologic therapy
Theoretical. Referring to therapy that do not involve drugs (Gale Encyclopedia of
Medicine, 2008).
Operational. Any of the following lifestyle modifications documented in the plan
of care for patients with elevated blood pressure such as smoking cessation, moderation
of alcohol consumption, weight loss, diet changes, and physical activity levels to control
blood pressure.
Assumptions
For this study, the following assumptions were made:
1.

Primary care providers in the clinical settings are aware of the guidelines
established by the 2017 AHA Hypertension Guidelines regarding elevated blood
pressure.

2.

Documented blood pressure and patient education provided within each patient's
record is correct and current.

3. Data collected to determine if providers are following the 2017 AHA
hypertension guidelines could be measured by examining medical records.
4.

Data collected is correctly interpreted by the researchers.

5. Results will be applicable to the general primary care provider population.
Limitations of the Research Project
Limitations of this study include the quantitative, retrospective design and the
small sample size of 108 charts reviewed in the Southeastern United States. The Covid-
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19 pandemic restricted non-employed staff members into clinics which limited access to
corporately- owned clinics due the Institutional Review Board guidelines. Researchers
also reviewed a variety of charting systems. Lastly, there was a strict time frame for
researchers to collect data and completion of the project.
Summary
The primary goal of this study is to evaluate primary care providers' use of the
2017 AHA Hypertension Guidelines. By implementing these guidelines and recognizing
elevated blood pressure, primary care providers should follow-up with patients in three to
six months and educate these patients with elevated blood pressure on nonpharmacologic
therapies. When treatment of elevated blood pressure is started early, development and
progression of complications from hypertension can be slowed or eliminated by utilizing
the recommended 2017 AHA Hypertension Guidelines. Mississippi is ranked in the top
five on the list of states with the highest hypertension rates (National High Blood
Pressure Annual Report, n.d.). Primary care providers can impact this statistic greatly by
following current 2017 AHA Hypertension Guidelines for elevated blood pressure.
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Chapter II: LITERATURE REVIEW
The purpose of this study is to determine if primary care providers are
implementing the guidelines set forth by the 2017 AHA Hypertension Guidelines
regarding interventions to prevent hypertension by managing elevated blood pressure.
The following chapter is a review of research literature that supports the purpose of the
research and theoretical framework. The first section explains articles and studies that
have utilized Nola Pender’s Health Promotion Model (HPM) as its theoretical
framework. The theoretical framework of the current study is based on HPM. The second
section of this chapter reviews related research that relays the impact of the problem. The
third section analyzes research that utilizes the guidelines the current research is based
upon. All of the reviewed research will show validity and support the conceptual
framework.
Conceptual Framework
T.Y Wu and Nola Pender conducted a panel study of the physical activity of youth
in an urban area of Taiwan. The HPM was used as the theoretical framework of this
study. Wu and Pender hypothesized that personal factors such as gender, socioeconomic
status, perceived benefits, perceived barriers, perceived self-efficacy, and interpersonal
influences all played a role in how much and often the youth would be physically active.
This was a two-year study that interviewed 8th and 9th graders about their physical
activity (Wu & Pender, 2005).
The study proved Wu and Pender’s hypothesis correct. All the factors played a role
either directly or indirectly in whether the youth engaged in physical activity. The HPM
was used in the finding and the suggestions for engaging Taiwanese youth in physical
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activity. It was suggested that having interpersonal influences which encouraged physical
activity or were physically active could alter the perceived benefits and barriers for the
youth (Wu & Pender, 2005). This finding and use of HPM in the research is comparable
to how the current study will be using HPM to guide the research.
Doubova, Martinez-Vega, Aguirre-Hernadez, and Perez-Cuevas conducted a crosssectional study of two-family medical clinics in Mexico to see if there was a relation
between hypertension-related distress and lack of self-care. The HPM was used as the
theoretical framework for this research. There were four areas of lack of self-care that the
researchers were interested in. Those areas were lack of physical exercise, not taking
hypertensive medications as prescribed, low dietary intake of vegetables and fruits, and
high intake of high-salt foods (Doubova et al., 2016).
The results of the study discovered that lack of physical exercise and low dietary
intake of vegetables and fruit were associated with hypertension-related distress. The
study also discovered that these patients were not educated on or did not understand the
importance of these activities in relation to hypertension (Doubova et al., 2016). These
findings correlate with the current study because if interpersonal influences can stress the
importance and supply education to the patient, then the patient will have a perceived
benefit to self-care.
Review of Related Research
The following research findings were reviewed to highlight literature related to
the current study. The previous research signifies the importance of primary care
providers implementing 2017 AHA Hypertension Guidelines to prevent hypertension and
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associated complications. The reviewed literature also concentrates on the outcomes and
barriers of non-pharmacological therapy for hypertension.
Muntner, Carey, GIdding, Jones, Taler, Wright, and Whelton (2018) performed a
retrospective cohort study to determine the prevalence of hypertension after the
introduction of the 2017 American College of Cardiology/American Heart Association
(ACC/AHA) guidelines compared to the prevalence of hypertension, and the required
pharmacology therapy noted with Joint National Committee of Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC7). The implementation of the
2017 ACC/AHA guidelines lowers the parameters previously set by the JN7 guidelines as
well as include nonpharmacologic therapies as potential treatment rather than advising
the initiation of antihypertensive medications. According to the ACC/AHA and JNC7
guidelines, 45.6% of US adults had a diagnosis of hypertension, and 36.2% were
recommended for antihypertensive therapy (2017). This is a major issue for primary care
providers because, most often, these are the providers who diagnose hypertension. No
theoretical framework was identified in this study.
The purpose of this study by Muntner et al. (2018), was to determine the
prevalence of hypertension and the number of patients for whom antihypertensive
medication was recommended according to the ACC/AHA and JNC7 guidelines. The
authors compared the two sets of guidelines to determine, which led to a higher
percentage of patients diagnosed with hypertension and the percentage of patients using
an antihypertensive treatment. Each guideline was examined separately, then compared
against each other.
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To conduct this study, data from the 2011-2014 National Health and Nutrition
Examination Survey based in the United States were analyzed. Each participant had a
medical evaluation at a mobile examination clinic and completed a standardized
questionnaire. The study included patients at least 20 years of age with three recorded
measurements of systolic and diastolic blood pressure readings during their examination.
Restrictions included patients who did not have three blood pressure measurements,
patients who were missing data on medication information, and patients who were
missing certain variables used to calculate CVD risk. After restrictions, the researchers
were left with a sample size of 9,623 participants.
Each participant was required to have three documented blood pressure
measurements. These were measured by trained physicians with appropriate equipment.
Blood pressure was obtained from each individual after 5 minutes of rest and at 30second intervals. The mean of the three measurements was used to classify systolic and
diastolic blood pressure. After the examination was complete, data was analyzed and
placed into five categories based on the ACC/AHA guidelines, participants not taking
any antihypertensive medication with blood pressure measurements of <120/<80, 120129/<80, 130-139/80-89, >140/90, and participants taking antihypertensive medication.
According to this study, it was determined that 45.6% of US adults had
hypertension according to the 2017 ACC/AHA guidelines versus 31.9% of US adults
according to the JNC7 guidelines (2018). Researchers also determined that when
following the ACC/AHA guidelines, antihypertensive medication was recommended for
36.2% of US adults, whereas 34.3% of US adults were recommended antihypertensive
medication when following the JNC7 guidelines (2018). The ACC/AHA guidelines
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identified 103.3 million US adults with hypertension compared to the JNC7 guidelines,
which identified 72.2 million US adults with hypertension (2018). Additionally, the study
shows that there was an increase in the percentage of US adults who were recommended
antihypertensive medication according to the ACC/AHA guidelines when compared to
the JNC7. The 2017 ACC/AHA guidelines showed that 21.4 million US adults met the
criteria for the treatment of nonpharmacological therapy without the addition of any
antihypertensive medication (2018).
This study presented several strengths. Using the NHANES survey allowed a
large sample size through broadening the generalizability of findings. Blood pressure
was also obtained by trained physicians using a specific protocol with specialized
equipment. A limitation of the study was that all three blood pressure readings were
obtained during a single visit, rather than multiple visits at different intervals. The
guidelines evaluated indicate that blood pressure measurements should be obtained from
two or more visits, and then a mean should be determined before a diagnosis of
hypertension is given.
The results of this study apply to current research interests for many reasons. This
study identifies the differences between past and current guidelines used by primary care
providers to diagnose hypertension. It also helps statically support the idea of how
prevalent hypertension is among adults in the US. Nonpharmacological therapy was also
included in the study when following the ACC/AHA guidelines to help identify the
percentage of adults that were not yet recommended for antihypertensive medication.
This information helps support the current research question by addressing these
nonpharmacologic therapies in prehypertensive patients to prevent the future diagnosis of
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hypertension. Through the implementation of ACC/AHA guidelines, preventive
measures can be taken in the elevated blood pressure stage to prevent a diagnosis of
hypertension.
Impact of Problem
Yano, et al. (2017) studied the association of blood pressure levels in young
adulthood and middle-aged cardiovascular events. Yano et al. used analyses conducted of
the prospective cohort Coronary Artery Risk Development in Young Adults (CARDIA)
study. The study used the 2017 American College of Cardiology/American Heart
Association (ACC/AHA) guidelines. These guidelines define normal blood pressure as
systolic blood pressure (SBP) less than 120 mm Hg and diastolic blood pressure (DBP)
less than 80 mm Hg. Elevated blood pressure was defined as SBP of 120 to 129 mm Hg
and DBP less than 80 mm Hg. Stage 1 hypertension was defined as SBP of 130 to 139
mm Hg or DBP of 80 to 89 mm Hg, and stage 2 hypertension as SBP 140 mm Hg or
above and DBP 90 mm Hg or above. No theoretical framework was identified for this
study.
Using the 2017 ACC/AHA guidelines, Yano, et al. assessed whether young adults
who developed hypertension or elevated blood pressure before the age of forty had a
higher risk of cardiovascular events than those young adults who maintained normal
blood pressure.
The study was conducted in Birmingham, Alabama; Chicago, Illinois;
Minneapolis, Minnesota; and Oakland, California. The final sample size was 4,851
participants. The participants were African American and white adults ranging from 1830 years old at the study onset in 1985. Data collected from participants included
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education level, height, weight, tobacco use, medications used, fasting lab values,
physical activity, and history of diabetes and CVD and had follow-up examinations at 2,
5, 7,10,15, 20, 25, and 30 years. The time frame was from 1985 to 2015. Blood pressure
was measured consistently, and a mean was taken of the second and third blood pressure
to ensure accurate blood pressure readings. Participants were categorized by blood
pressure reading following the 2017 ACC/AHA guidelines for normal blood pressure,
elevated blood pressure, stage 1 hypertension, and stage 2 hypertension.
Yano, et al. analysis of the CARDIA data showed that African-Americans were
more likely to develop elevated blood pressure, stage 1 hypertension, and stage 2
hypertension before 40 than compared to white adults. The study also found that men
were more likely to develop elevated blood pressure, stage 1 hypertension, and stage 2
hypertension before the age of 40 than women. Events of CVD were highest in the stage
2 hypertension group (8.04), followed by stage 1 hypertension (3.15), elevated blood
pressure was next (2.74), and last was normal blood pressure (1.37) (p < .01). The study
findings show that a young adult under the age of 40 who develops elevated blood
pressure, stage 1 hypertension, or stage 2 hypertension has a greater risk of developing a
CVD event than those adults with normal blood pressure as defined by the 2017
ACC/AHA guidelines. Future research would be recommended to determine what nonpharmacological and pharmacological interventions in young adults would be optimal for
a reduction in CVD events.
A strength of this study was the large sample size of both African-American and
white young adults. The researchers maintained a high retention rate of participants. They
also had an education and standardized system of collecting the data for the study. The
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study's limitations included other racial and ethnic groups not included in the study;
participants were treated with antihypertensive medications at a higher rate than the
general population. Blood pressure collection was in a highly controlled environment and
may not reflect what the blood pressure was day to day. Lastly, sodium intake and
psychological factors were not measured during this study.
This study is relevant to the current study for various reasons. The classifications
of blood pressure used in this study are the same as the current study. This study also
shows the significance of the different blood pressure levels and their effect on the risk of
CVD events. This study found an elevation in blood pressure above normal greatly
increases the risk of CVD events, this includes elevated blood pressure. If elevated blood
pressure were diagnosed, treated, and controlled, the risk of CVD events would be
reduced. The current study focuses on if the provider diagnoses elevated blood pressure
and follow the 2017 AHA Hypertension Guidelines for treatment and follow up.
Evidence from Yano et al. study emphasized this importance. If elevated blood pressure
is treated and blood pressure is reduced, the patient's chances of having a CVD event
would also be reduced.
Utilization of Guidelines
Lopez, et al. (2019) used a modified stepped-wedge quasi-experimental study
design to determine if electronic health record interventions would improve hypertension
control among patients in predominantly South Asian immigrant neighborhoods in New
York City. The Centers of Disease Control partnered with the Centers for Medicare and
Medicaid Services (CMS) to launch health initiatives targeting hypertension, one of the
leading risk factors for cardiovascular disease. However, New York City's South Asian
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immigrants' population have been identified in this study to have an elevated prevalence
for hypertension, but the clinics they attend have not been utilizing or are not aware of
the new health initiatives by the CDC and CMS. The new health initiatives include
clinical decision-support systems (CDSS) which are embedded within the electronic
health record. CDSS helps the provider identify at-risk patients and alerts the provider
when cardiovascular disease risk factors are not in recommended parameters.
Lopez et al. hypothesis was that if the electronic health record had certain
interventions that were tailored to the South Asian immigrant population and the
physicians and medical staff were educated on interventions, hypertension in the South
Asian immigrant population would be better controlled over a 12-month study.
The study was conducted in 14 practices with operating electronic health records
located in largely South Asian neighborhoods of New York City. These practices' patient
population had to be 70% South Asian to participate in the study. The practices also had
to have either eClinicalWorks or MDL and electronic health records for the last 12
months. There were four rounds of implementation three months apart. The interventions
to the electronic health records were generating hypertension patient registry reports and
developing and implementing alerts and order sets. Education was given to providers and
staff in a 2-day training period. The education included the importance of generating
hypertension patient registry reports to help staff identify the need for follow-up
appointments for patients with diagnosed hypertension who had an uncontrolled blood
pressure reading at their last visit. Education was also given on the medical alerts and
order sets. Medical alerts would help the physician recognize what patient is in need of
intervention. Order sets would help guide the physician to interventions such as
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laboratory tests, prescriptions, counseling orders that would be printed in materials
tailored to the South Asian population. The physician could bypass these order sets if
deemed necessary.
Post interventions, the researchers found their hypothesis statistically supported.
They found, on average, the systolic blood pressure decreased 1.71 mm Hg and diastolic
blood pressure decreased 1.13 mm Hg (p <0.05). The researchers also interviewed the
clinics to find their perspectives of the study. All 14 of the practices reported that the
hypertension patient registry helped them identify what patients needed follow-up
appointments and prioritize the uncontrolled hypertensive patients. All 14 of the practices
also agreed they were prepared to use medical alerts to improve hypertension practices.
Eleven of the fourteen stated that they were willing to use order sets to improve
hypertension management.
Lopez et al. identified several limitations to the study. First, the study was a
nonrandomized design for convenience. Secondly, there were data discrepancies due to
the use of two different electronic health records. Lastly, the providers could bypass
alerts and order sets, so this was not a valid assurance they were used every time.
The study is relevant to the current study for various reasons. The basis of this
study is intervening with the healthcare providers to better manage hypertension, which is
similar to our study to ascertain if healthcare providers are diagnosing elevated blood
pressure and managing it before it becomes hypertension. Secondly, this study focuses on
the South Asian immigrant population of New York City. It will be interesting to see if
the current study uncovers an ethnic group that is being under-diagnosed.
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Warren-Findlow, et al. (2019) used a cross-sectional study to examine
hypertension self-care behaviors adherence and benefit outlined by the seventh report of
the Joint National Committee (JNC7) by using the Hypertension Self-Care Activity Level
Effects (H-SCALE) questionnaire. In the United States, hypertension continues to be
widespread. The 2017 American College of Cardiology guidelines defines elevated blood
pressure as systolic blood pressure (SBP) between 120-129 mmHg with diastolic blood
pressure (DBP) less than 80 mmHg, stage 1 hypertension as SBP equal to or greater than
130mmHg and DBP equal to or greater than 80 mmHg, and stage 2 hypertension as SBP
equal to or greater than 140 mmHg and DBP equal to or greater than 90 mmHg. There
are six hypertension self-care behaviors defined by the JNC7. Those behaviors include
adherence to prescribed hypertension medication, tobacco cessation, moderate alcohol
consumption, weight management, a healthy diet, and physical activity. The researchers
used the H-SCALE because it addresses all six behaviors. The H-SCALE has been used
in other studies to address patient adherence to hypertension self-care behaviors. There
was no theoretical framework identified in this study.
Warren-Findlow, et al. (2019) posed several questions to be answered by their
research. They wanted to test the H-SCALE’s ability to forecast blood pressure
management by hypertension self-care behaviors. The researchers wanted to measure the
adherence to the hypertension self-care behaviors and the effects on the control of blood
pressure. Lastly, the researchers believed that their findings would help guide healthcare
providers in counseling patients in these behaviors for better blood pressure control.
This was a cross-sectional study in North Carolina. The data was gathered from
three studies that used the H-SCALE. There are 79 participants, and all were diagnosed

33
with hypertension before the studies began. The demographics of the study were equally
distributed between Caucasian, African American, and Hispanic. The majority of
participants were female at 54%. The mean age was 54.1. The participants were selected
in several ways, varying by the study. One of the studies recruited by a primary care
clinic staff, one recruited by email, and the last study had staff recruited at a special clinic
of a major regional hospital. The H-SCALE is a questionnaire that addresses the six
hypertension self-care behaviors. The H-SCALE provides a score based on the
participants’ answers to questions geared to each behavior. The researcher then correlated
the SBP and DBP of the participants with their H-SCALE scores.
The results of the study found that 89% of participants adhered to moderate
drinking, 82% to limited tobacco exposure, 56% to the medication regime, 49% to
physical activity, 39% to weight management, and 18% to a healthy diet. One major
difference was found when comparing race. African Americans were found to have lower
medication adherence percentages compared to the Caucasians and Hispanic
counterparts. There were no differences between age and gender found. It was found that
physical activity adherence had the biggest impact on both SBP and DBP control (p<.01).
A healthy diet and adherence to medication showed an impact on blood pressure control.
The study also showed that overall adherence to all the behaviors promoted blood
pressure control. The researchers suggested for future research to include elevated blood
pressure and focus on non-pharmacological management. They also suggested further
research studying physical activity and its impact on blood pressure control.
The study’s strength was equal representation of gender and the Caucasians,
African Americans, and Hispanics. However, not all races and ethnicities were
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represented in this study. Another weakness of the study was the small sample size, all
from North Carolina. The participants were also taking different medications, and some
were taking multiple medications.
The current study is focusing on elevated blood pressure management by primary
healthcare providers. Are the primary healthcare providers educating the elevated blood
pressure patients on non-pharmacological behaviors and following up with the patients as
suggested by the 2017 AHA Hypertension Guidelines? The results of this study showing
the positive impact of all behaviors, especially physical activity, gives validity to the
current study focusing on non-pharmacological management. The only behavior that
would not be addressed in the current research would be medication adherence, which
was identified as the most educated by providers in this study.
Gao et al. (2015) performed a retrospective cohort study to identify the impact of
ideal cardiovascular health behaviors and factors on the development of hypertension in
prehypertensive subjects. Globally estimated, elevated blood pressure contributes to 62%
of cerebrovascular disease and 49% of ischemic heart disease (Gao et al., 2015). Primary
care providers must provide necessary information to prehypertensive subjects to delay or
prevent hypertension and cardiovascular events. No theoretical framework was identified
in the study.
Gao et al. sought to examine the effects of ideal health behaviors and factors on
the incidence of new-onset hypertension in the prehypertensive population. The purpose
was to exercise the usage of 2017 AHA Hypertension Guidelines for the prehypertensive
community and determine the impact on the outcome.
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The study was conducted prospectively in a cohort from the KaiLuan community
in Tangshan City, Hebei Province, China. Baseline health records of 101,510 participants
aged 18-98 years were initially documented from 2006-2007 and then updated every two
years during the follow-up until 2013. Those whose systolic BP of 120-139mmHg or
diastolic BP of 80-89mmHG were eligible for inclusion in this study. The participants
were not being treated with any antihypertensive medications. The participants were also
screened for no pre-existing condition of stroke, myocardial infarction, or malignancy.
Those with incomplete baseline data on health behaviors and factors were also excluded.
The final cohort consisted of 32,887 (26,352 males and 6,535 females) Spanish residents
with a mean age of 49.51 + 11.94 years.
BMI was calculated after collecting the participants' height to the nearest 0.1cm
and body weight to the nearest 0.1kg. BP was checked three times with a 2-min interval
using a standard mercury sphygmomanometer and appropriately sized cuff and measured
to the nearest 2mmHg. The average of the three readings was used for analysis.
Measurements of blood included plasma triglyceride, total cholesterol, high-density
lipoprotein, low-density lipoprotein, fasting blood glucose, and high-sensitivity Creactive protein.
Cardiovascular health was screened with questionnaires by healthcare providers.
Smoking status was described as never, former, and current. Physical activity was
expressed as never, occasional, and regular (>3 times per week, lasting 30minutes or
more). Alcohol consumption was defined as the daily drinking of any alcoholic beverage
for at least one year. Optimal dietary metrics of low salt intake were identified as low,
medium, or high (Gae et al., 2015, p.651).
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The 32,887 participants were then divided into five groups: Group <1, carrying
none or one ideal health metric, groups 2,3, and 4, having 2, 3, and 4 ideal health metrics,
and group > 5, carrying 5 or 6 ideal health metrics. New-onset hypertension would be
diagnosed if the participant (1) follow up reading systolic BP >140mmHg or diastolic
>90mmHg; (2) current use of antihypertensive medication.
Within the 32,887 prehypertensive participants, only 3.56% had > 5 ideal health
metrics, and 10.24% had <1 ideal health metrics. The ratio of participants who had 2,3
and 4 ideal health metrics was 24.99%, 36.89%, and 24.35%. Within the prehypertensive
population, 15,500 developed new-onset hypertension during the study. The occurrence
of hypertension within the participants was 47.13% (49.03% males and 39.46% female).
For each health metric group, the incidence of hypertension was relatively higher in
males than in females. Cumulative incidence of hypertension was 78.61%, 71.08%,
63.15%, 56.07%, and 61.62% in prehypertensive individuals carrying <1, 2, 3, 4, and > 5
ideal health behaviors or factors, respectively. The relative risk of incident hypertension
was lower in subjects with >4 metrics than that <3; it decreased by 14.3 % for every
increase in the number of ideal cardiovascular health metrics. Therefore, health education
and lifestyle changes are greatly needed to delay or prevent hypertension in
prehypertensive individuals.
The research did have weaknesses noted. Gao et al. (2015) identified the gender
ratio; the male to female ratio was 4:1. Another limitation reported by Gao et al. (2015) is
the broadness of the amount of alcohol and salt consumed.
Strengths of the study Gao et al. (2015) reports include the sample size, with over
thirty thousand participants, and the duration of the follow-up lasting 52 months.
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This study applies to the current research study in numerous ways. This current
research will focus on the usage of the 2017 AHA Hypertension Guidelines for
prehypertension patients to prevent hypertension. This study relates to our research
because it identifies the large percentage of hypertension prevalence in prehypertension
individuals with limited ideal health factors. Our research focuses on the importance of
the implementation of the 2017 AHA Hypertension Guidelines for prehypertension
patients. Primary care providers should follow the 2017 AHA Hypertension Guidelines
for prehypertension individuals and increase their ideal health factors to prevent
hypertension.
Crittenden, et al. (2017) performed this study using a prospective prepost design
to identify the effects of health coaching on hypertension management. The study was
approved by the institutional review board and the physician of the clinic in which the
study was conducted. Hypertension is among the top leading causes of death in the
United States. Despite the prevalence of this disease, it is often uncontrolled. Many
medications are available for the treatment of hypertension. However, guidelines set forth
by the American Heart Association, American Stroke Association, and the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood pressure
also advise the use of lifestyle modifications. Researchers identified a gap in the
provider's assessment of lifestyle modifications. They found a lack of commitment often
caused this. Pender's Health Promotion Model was used during this study. Patients were
shown lifestyle modifications and were encouraged to choose the one they felt most
appropriate.
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Crittenden, et al (2017) sought to identify the positive effects of health coaching
in relation to the treatment of hypertension. They felt that providing patients with
appropriate education materials and encouragement would positively influence the
management of hypertension. Researchers also wanted to identify the barriers faced by
providers when assessing lifestyle modifications.
This study was performed at a family practice physician's clinic that was privately
owned. One nurse practitioner participated and took on the role of the health coach.
Participants included patients aged nineteen and older who responded to a flyer at the
clinic. Patients included only those with a hypertension diagnosis. After criteria were
applied, a sample size of twenty-one adults ranging in age from thirty-one to seventythree years. The majority of the sample was females over the age of fifty. Patients were to
select a lifestyle modification that they felt most attainable. Options included weight
control, regular exercise, dash diet, no salt added diet, decrease tobacco use, and manage
stress—the health coach individualized treatment plans for each patient. Education tools
utilized included the Measure Up/Pressure Down Toolkit and the Morisky Medication
Adherence Scale 8. Patients were given fifteen minutes of education. The study was
conducted over eight weeks. During this time, patients were instructed to record their
blood pressure three times a week. The health coach called each patient twice per week to
evaluate patients' adherence to the plan and identify the barriers they were facing.
The study showed that the continuation of health coaching positively impacts the
management of hypertension. Patients were more likely to follow lifestyle modification
plans when they felt support and encouragement from the health coach. Before the study,
twelve participants stated they were unaware of the optimal blood pressure reading.
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Fourteen of the twenty-one participants stated they did not follow through on lifestyle
modification plans and seventeen of the twenty-one stated they did not follow their
medication plan. Following the study, participants were more aware of all aspects of
their hypertension management.
Several barriers were identified throughout this study. The study was conducted at
one clinical site providing a small sample size. It also only included patients with a
diagnosis of hypertension. Researchers also found that some patients did not have access
to blood pressure monitors at home and required transportation to locations in the
community to have it checked. Not including family or caregivers also posed a barrier to
the study. Patients who were able to monitor blood pressure at home and saw the positive
impact of the lifestyle modifications were more likely to continue with the treatment plan.
This study applies to the current research for several reasons. Researchers were
able to determine that coaching and encouragement had a positive influence on patient
outcomes. They focused more on non-pharmacological therapies in the treatment of
hypertension. The current research focuses on non-pharmacological therapies in the
treatment of elevated blood pressure. This study informs providers that there is a potential
to utilize education and encouragement early on and potentially avoid a diagnosis of
hypertension. Each patient should have an individualized treatment plan along with
education materials and positive reinforcements in their treatment plan.
Barriers
Johnson, Warner, Bartels, and LaMantia (2017) performed a multicenter
qualitative study to identify primary care providers' perspectives on barriers to managing
hypertension in young adults who seek regular primary care. This study also identified
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barriers that primary care providers face when diagnosing, treating, and controlling
hypertension. Researchers were given approval from the University of WisconsinMadison Health Sciences Institutional Review Board prior to beginning this study.
Hypertension is a significant risk factor for cardiovascular disease. Identifying,
diagnosing, and controlling hypertension in young adulthood can reduce the risk of heart
failure, stroke, and chronic kidney disease. According to this study, approximately 20%
of young adults aged 18-39 years have hypertension. And of this 20%, only 36% of these
individuals have it under control. Prior to this study, no research was available
specifically to help understand the cause of this lack of control among this age group. The
lack of research fueled researchers to perform this study in order to examine specific
barriers primary care providers face each day when treating young adults with
hypertension. No theoretical framework was identified throughout this study.
Johnson et al. (2018) sought to identify a gap in the control rates of hypertension
among young adults versus mid-to-older adults. They wanted to understand these barriers
better to assist in developing interventions that could increase the control rate of
hypertension among young adults. Ultimately, researchers were determined to identify
these barriers so that primary care providers could overcome these obstacles to improve
treatment and control hypertension.
This study was conducted at three family medicine/family practice clinics in
Wisconsin. The clinics were located in different counties and included an academic
community clinic, an urban clinic, and a rural clinic. Sixty-minute, one-on-one interviews
were conducted by a trained research assistant at each provider's clinic. Primary care
providers were invited to participate through email and given an honorarium for their
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participation. This study's inclusion criteria included practicing physicians, such as
medical doctors and doctors of osteopathic medicine, and advanced practice providers,
such as physician assistants, nurse practitioners. With a clinical patient group of young
adults with uncontrolled hypertension. After the criteria were applied, nine primary care
providers, seven physicians and two nurse practitioners, participated in the interview
process. Interviews were conducted from May 2014 through October 2014. A semistructured interview guide was used throughout the process. The interview consisted of
16 questions relating to the providers' diagnostic range of blood pressure readings, the
reluctance to initiate antihypertensive medications, and the application of hypertension
guidelines to young adults compared to mid-to-older adults.
Researchers were able to identify several barriers that primary care providers
encounter when treating young adults. These providers all agreed that the Joint National
Committee 8 (JNC 8) guidelines applied to all adult age groups, young to old. They also
decided that 3-6 months of lifestyle modification should be the first-line defense in
treating hypertension rather than early initiation of antihypertensive medications unless
the patient had significantly elevated blood pressure. Psychosocial barriers were also
identified, mainly supporting the idea that young adults did not want to be considered
"sick". Providers believe patients were reluctant to accept hypertension diagnosis,
therefore leading them to be non-compliant with lifestyle modifications, medication
regimes, and follow-up appointments. Antihypertensive medication initiation was also
often delayed for this age group due to the risks of interactions with other medications
such as ADHD medication and oral contraceptives. Follow-up visit adherence also was
noted as a barrier for providers. They were unwilling to prescribe antihypertensive drugs
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that required frequent visits for subsequent lab checks because this age group often
cancels or does not show up for follow-up appointments. The overall lifestyle of young
adults often deters providers from diagnosing and treating hypertension.
The use of different clinical sites to conduct this study can be identified as a
strength of the analysis. The researchers included different primary care providers from
an academic, a rural, and an urban healthcare clinic throughout Wisconsin. Also, a
trained research assistant performed all interviews ensuring construct validity. A
limitation of the study is that the clinics were predominantly the white race. This limits
the study and does not identify the barriers faced in other regions or races. The study also
had a limited number of providers interviewed. With a larger number of providers,
additional barriers could be identified.
This study pertains to the current research for several reasons. Through the
identification of these barriers, primary care providers can improve their treatment of
prehypertension and hypertension. All the providers interviewed agreed that 3-6 months
of lifestyle modification was needed before antihypertensive medications. This supports
the current research, which focuses on nonpharmacological interventions as treatment for
elevated blood pressure. Primary care providers' perspective is crucial because it shows
how likely they are to adhere to the treatment guidelines. Primary care providers must
overcome these barriers to implement the guidelines and achieve successful outcomes for
each patient.
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CHAPTER III: METHODOLOGY
This study focuses on the implementation of the 2017 AHA Hypertension
Guidelines by primary care providers. Through the use of these guidelines, primary care
providers are able to identify elevated blood pressure and begin treatment with nonpharmacological therapies to prevent a diagnosis of hypertension, the leading modifiable
risk factor of strokes.
The purpose of this study was determine if primary care providers were
implementing the guidelines set forth by the AHA regarding interventions to prevent
hypertension. The primary focus was patients without a diagnosis of hypertension. By
following the 2017 AHA hypertension guidelines, primary care providers can intervene
early when a patient has elevated blood pressure. Patients can be educated on
nonpharmacological interventions listed in the guidelines to modify their diet and
lifestyle to reduce their risk of progressing to a hypertension diagnosis. The researchers
sought to determine if providers were monitoring patients by documenting a follow-up
appointment within 3 to 6 months of elevated blood pressure readings and provided nonpharmacological therapies to prevent a further diagnosis of hypertension.
Design of the Study
A quantitative, retrospective design was used by researchers to determine whether
or not primary care providers were implementing the 2017 AHA Hypertension
Guidelines by following up with patients who show an elevated blood pressure in three to
six months as well as providing education on non-pharmacological therapies that can be
used to reduce their risk of developing hypertension. This design was appropriate because
it allowed researchers to pull data from accessible clinics, once consent was been
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obtained, review a large number of charts, and collect documented data surrounding
follow up appointment times and education to patients during their visit.
Setting for the Research Project
This study was conducted in four primary care clinics in the Southeastern United
States. The researchers collected data between the hours of 8am and 5 p.m. under staff
supervision.
Population and Sample
The study was completed at four primary care clinics in the Southeastern United
States. A convenience sample was used for the study. The target population for the study
included patients without a confirmed diagnosis of hypertension, 18 years of age or older,
in the Southeastern United States.
Methods of Data Collection
A retrospective chart review was conducted. Data collected remained confidential
and did not contain any patient or provider identifying information. There was no direct
patient contact. Data was entered into a Microsoft excel document and stored on a flash
drive that was accessible to the four student researchers involved in the study. Consent
was also obtained from each clinic manager before collecting any data from the patient
charts. After obtaining consent from Mississippi University for Women’s Institutional
Review Board, each of the four members of the research group reviewed 100 patient
charts per clinic.
They also verified documentations that patients were educated on
nonpharmacologic therapies to better manage elevated blood pressure. The researchers
used a student derived data collection tool to extract data regarding the practices of
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primary care providers by reviewing documentation in the medical record between
January 2019 and December 2020. Electronic and paper charts were reviewed during the
data collection stage. Charts were included if they met inclusion criteria for the study
listed above. Exclusion criteria included patients under the age of 18 years old and
patients who had a previous diagnosis of hypertension.
Methods of Data Analysis
Research was conducted and recorded on a research data tool that was created by
the researchers. The tool included the following demographic information: age, gender,
race, provider type, and payor source. The tool also addressed the research questions
regarding elevated blood pressure readings and documentation of nonpharmacological
treatments and follow up. Data was compiled into a Microsoft excel document and then
sent to a statistician for formal analysis using percentages. Data was analyzed using SPSS
27. Chi-square tests of association were conducted to analyze the relationship between
study variables.
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Chapter IV: Results
As literature supports, approximately 1.13 billion people around the world have a
confirmed diagnosis of hypertension (WHO, 2019). The WHO lists hypertension as one
of the major causes of premature death, labeling it as the “silent killer” because so many
people are unaware they even have this condition until it is too late (WHO, 2019). In the
United States, 1 out of 2 adults have hypertension (Million Hearts, 2020). Elevated blood
pressure, if left untreated, can progress to hypertension. By following the 2017 AHA
Hypertension Guidelines, elevated blood pressure could be identified and treated through
the use of nonpharmacological therapies to prevent the progression of hypertension.
The primary goal of this study was to evaluate Mississippi’s primary care
providers' use of non-pharmacological treatment of elevated blood pressure in patients
without a previous diagnosis of hypertension who are 18 years or older. The nonpharmacological treatments for elevated blood pressure included weight loss, exercise,
diet recommendations, potassium supplementation, limitation of alcohol, and smoking
cessation. After examining treatment practices regarding elevated blood pressure, the
study then determined if a follow up visit was scheduled within three to six months or
within one year.
The research was conducted using a quantitative, retrospective design to
determine if primary care providers are implementing 2017 AHA Hypertension
Guidelines regarding follow up for elevated blood pressure. The research also evaluated
if education on non-pharmacological therapies that can be used to reduce their risk of
developing hypertension was done. Electronic and paper charts were reviewed.
Participants included patients 18 years and older with no previous diagnosis of
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hypertension. The charts were systematically selected by reviewing every third chart.
Data was extracted and recorded using a research tool created by the researchers. Data
was collected from charts between January 2018 and April 2021. Although 400 charts
were reviewed, only 108 charts were included due to exclusion criteria of age, date of
visit, and current diagnosis of hypertension. In the remainder of this chapter, we will
discuss the statistical findings of the chart review.
Profile of Study Participants
Age: The sample population was divided into 18-44 years of age and 45 years of
age or older. Of the sample population, 64.8% were 18-44 years of age, while 35.2% of
participants were greater than 45 years of age or older.
Table 1
Age
Frequency

Percent

Valid Percent

Cumulative Percent

18-44

70

64.8

64.8

64.8

45+

38

35.2

35.2

100.0

Total

108

100.0

100.0

Gender: The sample population was divided into male and female. Of the
sample population, 34.3% were male, while 65.7% were female.
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Table 2
Gender
Frequency

Percent

Valid Percent

Cumulative Percent

Male

37

34.3

34.3

34.3

Female

71

65.7

65.7

100.0

Total

108

100.0

100.0

Race: The sample population was divided into Caucasian, African American,
and other. Of the sample population, 51.9% were Caucasian, 38% were African
American, and 10.2% were other.
Table 3
Race
Frequency Percent

Valid Percent

Cumulative Percent

Caucasian

56

51.9

51.9

51.9

African American

41

38.0

38.0

89.8

Other

11

10.2

10.2

100.0

Total

108

100.0

100.0

Provider Type: The sample population was divided based on the provider type.
The provider types included nurse practitioner, physician and physician assistant. The
providers were 82.4% nurse practitioners, 13% physicians, and 4.6% physician assistants.
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Table 4
Provider Type
Frequency Percent

Valid Percent

Cumulative Percent

NP

89

82.4

82.4

82.4

Physician

14

13.0

13.0

95.4

PA

5

4.6

4.6

100.0

Total

108

100.0

100.0

Payor Source: The sample population was divided into self-pay, commercial,
Medicare/Medicaid, private and none. Of the sample population, self-pay patients made
up 15.7%. commercial 63%, Medicare/Medicaid 17.6%, private 0.9% and none was
2.8%.
Table 5
Payor Source
Frequency Percent

Valid Percent

Cumulative Percent

Self-Pay

17

15.7

15.7

15.7

Commercial

68

63.0

63.0

78.7

Medicare/Medicaid

19

17.6

17.6

96.3

Private

1

0.9

0.9

97.2

None

3

2.8

2.8

100.0

Total

108

100.0

100.0
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Elevated Blood Pressure Documentation: The sample population was divided
into yes and no categories. In regard to elevated blood pressure documentation, 91.7% of
participants had an elevated blood pressure reading, while 8.3% of participants did not
have an elevated blood pressure reading documented.
Table 6
Did the patient have a documented elevated blood pressure of 120-129/<80?
Frequency Percent

Valid Percent

Cumulative Percent

Yes

99

91.7

91.7

91.7

No

9

8.3

8.3

100.0

Total

108

100.0

100.0

Interventions Documented: Of the sample population, 86.1% have
documentation to support that nonpharmacological treatment was performed. Only 13.9%
of participants received nonpharmacological treatment during their visit.
Table 7
Nonpharmacological treatment documented
Frequency Percent

Valid Percent

Cumulative Percent

No

93

86.1

86.1

86.1

Yes

15

13.9

13.9

100.0

Total

108

100.0

100.0
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Interventions Implemented: Of the sample population, 86.1% of the
participants did not have documentation to support that nonpharmacological treatment
was performed. The sample population indicated that 6.5% of participants received
education on weight loss, diet recommendations and exercise combined, while 1.9% of
participants were educated on diet recommendations and exercise. Smoking cessation
education was provided to 2.8% of participants. 0.9% of participants were educated on
exercise alone, and 1.9% of participants received education on weight loss only.
Table 8
If yes, was any of the following recommended nonpharmacological treatment
documented?
Frequency Percent
No

Valid Percent

Cumulative Percent

93

86.1

86.1

86.1

7

6.5

6.5

92.6

2

1.9

1.9

94.4

Smoking cessation

3

2.8

2.8

97.2

Exercise

1

0.9

0.9

98.1

Weight loss

2

1.9

1.9

100.0

Total

108

100.0

100.0

Weight loss, diet
recommendations,
exercise
Diet
recommendations,
exercise
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Statistical Results
The total sample population included 108 participants. Of the 108 participants,
13.9% were treated with nonpharmacological treatments. There was no statistical
significance when analyzing the relationship between demographic variables and the
documentation of nonpharmacological treatments. The analysis of the relationship
between provider type, payor source and documentation of nonpharmacological treatment
was also not statistically significant. The analysis of the relationship between payor
source and documentation of nonpharmacological treatment was significant. When
broken down further, there is significance between the type of nonpharmacological
treatment documented and the payor source. Providers were statistically more likely to
recommend weight loss, diet recommendations, and exercise to commercial insurance
patients.
Summary of Findings
A retrospective chart review of 400 charts was performed by the researchers. The
charts were reviewed at 4 primary healthcare clinics in the Southeastern United States.
The data was evaluated and recorded on a research data tool that included patient
demographics and research questions. Results show that the only significant factor when
providing nonpharmacological treatment was payor source. Results showed that no
particular provider included was more likely to follow guidelines when compared to
others. These results show staggering statistics to support that primary care providers are
lacking in the treatment of elevated blood pressure through the use of
nonpharmacological treatments.
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Chapter V: Implications
In 2017, the AHA released new guidelines regarding the management of
hypertension. These guidelines outlined new parameters for each category of blood
pressure measurements. Elevated blood pressure is now defined as a systolic blood
pressure ranging from 120-129 mm Hg and a diastolic blood pressure reading of less than
80 mm Hg (AHA, n.d.). The new 2017 AHA Hypertension Guidelines also state that if a
person exhibits an elevated blood pressure, the patient should be treated with
nonpharmacological treatment and then reassessed in 3-6 months. This research study
was conducted to evaluate primary care providers implementation of the 2017 AHA
Hypertension Guidelines in patients without a diagnosis of hypertension. Through early
detection and treatment using the guidelines, the progression of elevated blood pressure
to hypertension can be slowed or prevented altogether.
More than 700,000 people residing in Mississippi currently have a diagnosis of
hypertension (Mississippi State Department of Health, 2019). The true number of people
with hypertension is unimaginable because many people are unaware they even have
hypertension until they have obvious target organ damage prompting them to seek care
from their primary care provider. Once this target organ damage occurs, the patient is
already at an increased risk of heart disease and stroke.
Multiple literature reviews were conducted prior to the data collection.
Researchers identified in previous studies that primary care providers were often hesitant
to diagnose hypertension using the current guidelines. Primary care providers were more
likely to use JNC7 guidelines due to higher parameters for diagnosing hypertension even
though research indicates significant target organ damage occurs at these higher stages.
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Previous research also showed that young adults who developed hypertension or elevated
blood pressure were at an increased risk of cardiovascular events when compared to
young adults with normal blood pressure readings. The diagnosis of hypertension is
lifelong. Primary care providers often face barriers when developing treatment plans for
patients with elevated blood pressure or hypertension including patients’ denial of
diagnosis. Previous studies revealed that primary care providers feel that patients will be
non-compliant with lifestyle modifications, medication regimes, and follow-up
appointments because they do not see themselves as “sick”. Ultimately, the providers
should adhere to the 2017 AHA Hypertension Guidelines and intervene early to prevent
hypertension and subsequent target organ damage by implementing nonpharmacologic
treatments with elevated blood pressure. By early intervention, patients have the best
chance for positive outcomes in the future.
The goal of this research was to answer two questions. First, researchers wanted
to determine if primary care providers were educating patients on nonpharmacological
treatments if their blood pressure was found to be elevated. Second, researchers wanted
to determine if primary care providers were following up with patients within 3-6 months
who had a documented elevated blood pressure reading per the 2017 AHA Hypertension
Guidelines. A retrospective chart review was conducted to gather data. The remainder of
this chapter will address pertinent study findings as well as limitations and implications
of the current research. The researchers will also make recommendations for
improvement of future research.
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Summary of the Findings
The sample size of this study included 400 patient chart reviews. Of the 400
patient charts reviewed, 292 charts were ultimately excluded from the study due to a
previous diagnosis of hypertension. Therefore, the sample size of the study included 108
reviewed charts. The current research interest included patient charts without a previous
diagnosis of hypertension who presented with elevated blood pressure reading. Each
patient was treated in one of four primary care clinics in the southeastern United States
between January 1, 2018 and April 2, 2021. According to 2017 AHA Hypertension
Guidelines, primary care providers should initiate non-pharmacological measures and 3-6
month follow-up for individuals with elevated blood pressure. The sample included 37
(34.3%) males and 71 (65.7%) females. The sample consisted of 70 (64.8%) aged 18-44
and 38 (25.2%) aged 45 and older. The ethnicity of the sample consisted of 56 (51.9%)
Caucasian, 41 (38.0%) African American, and 11 (10.2%) other. The primary payor
source noted was commercial insurance at 63%, followed by Medicare/Medicaid at
17.6%, self-pay at 15.7%, none at 2.8%, and private pay at 0.9%. Nurse practitioners
were the primary care provider for 82.4% of the sample population, with physicians at
13% and physician assistants at 4.6%.
Of the charts reviewed, 93 (86.1%) had no non-pharmacological treatment
documented for patients with elevated blood pressure. The remaining 15 (13.9%) had
non-pharmacological treatment documented including: 6.5% percent were instructed on
weight loss, diet recommendations, and exercise, 2.8% were instructed on smoking
cessation, 1.9% were instructed on diet recommendation and exercise, 1.9% instructed on
weight loss, and only 0.9% were instructed on exercise only. This phenomenon
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demonstrated a lack of primary care provider adherence to the 2017 AHA Hypertension
Guidelines.
In addition to adhering to 2017 AHA Hypertension Guidelines by initiating and
documenting non-pharmacological treatments for elevated blood pressure, the guidelines
also states that the primary care provider should reassess patients with elevated blood
pressure in 3-6 months. Of the 108 patient charts with documented elevated blood
pressure, 4 (3.7%) of the patient charts had a documented follow-up appointment within
3-6 months. However, 104 (96.3%) did not have a documented follow-up appointment
within 3-6 months. This finding illustrated that the majority of primary care providers
are not adhering to the 2017 AHA Hypertension Guidelines. This non-adherence
contributes to the morbidity and mortality of patients with hypertension.
Furthermore, other results regarding demographic factors were collected. There
was no difference in primary care provider implementation of the AHA Hypertension
guidelines regarding non-pharmacological measures according to age, gender, or race;
however, there was a significant difference noted based on payor source. This disparity
could be because providers were more willing to schedule follow up appointments with
commercial-insured patients due to covered cost of an appointment. The lack of follow
up noted for non-insured patients could be attributed to financial burden for the patient.
Discussion of the Findings
This study found that of the 108 patient charts reviewed with elevated blood
pressure noted, only 15 charts had non-pharmacological treatment documented, and only
four charts had a 3-6 month follow-up appointment documented. This reveals that most
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primary care providers are not implementing the latest evidence-based guidelines for
diagnosing and managing elevated blood pressure. A study by Muntner, et al. (2018)
performed a retrospective cohort study to determine the prevalence of hypertension after
introducing the 2017 American College of Cardiology/American Heart Association
(ACC/AHA) guidelines compared to Joint National Committee of Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC7). The research data was
gathered from the 2011-2014 National Health and Nutrition Examination Survey based in
the United States. The study concluded that ACC/AHA guidelines identified 103.3
million U.S. adults with hypertension compared to the JNC7 guidelines, which identified
72.2 million U.S. adults with hypertension. In addition, the 2017 ACC/AHA guidelines
showed that 21.4 million U.S. adults meet the criteria for nonpharmacological therapy
without antihypertensive medication. This study identified the differences between past
and current guidelines used by primary care providers to diagnose hypertension. The
collected data support the current research question by addressing nonpharmacologic
therapies in prehypertensive patients to prevent the future diagnosis of hypertension.
Overall, the study performed by Muntner et al. (2018) displayed the importance of
primary care providers implementing the latest hypertension guidelines to prevent the
progression of blood pressure, which is similar to the purpose of this study.
Yano, et al. (2017) completed a study that focused on the association of
ACC/AHA 2017 blood pressure level in young adults younger than 40 and middle-aged
cardiovascular events. The analysis was performed in Birmingham, Alabama; Chicago,
Illinois; Minneapolis, Minnesota; and Oakland, California, with 4,851 participants. The
study findings show that a young adult under the age of 40 who develops elevated blood
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pressure, stage 1 hypertension, or stage 2 hypertension has a greater risk of developing a
CVD event than those adults with normal blood pressure defined by the 2017 ACC/AHA
guidelines. The concluded data showed that African Americans and men were more
likely to develop elevated blood pressure, stage 1 hypertension, and stage 2 hypertension
before 40 than white adults and women. This study is similar to the current research
demonstrating the importance of preventing hypertension by managing elevated blood
pressure according to the AHA guidelines to prevent CVD events.
Gao et al. (2015) performed a retrospective cohort study to implement the AHA
guidelines for the prehypertensive community and determine the outcome. The study was
based upon a KaiLuan community in Tangshan City, Hebei Province, China, including
32,887 participants. The occurrence of hypertension was 78.61%, 71.08%, 63.15%,
56.07%, and 61.62% in prehypertensive individuals carrying <1, 2, 3, 4, and > 5 ideal
health behaviors or factors, respectively. The relative risk of incident hypertension was
lower in subjects with >4 metrics than that <3; it decreased by 14.3 % for every increase
in the number of ideal cardiovascular health metrics. This study is significant in the
current study because it identifies the major influence of non-pharmacological measures
to prevent hypertension.
The studies conducted by Muntner et al. (2018), Yano et al. (2017), and Gao et al.
(2015) all contributed to this study by concentrating specifically on the AHA
Hypertension Clinical Practice guideline. Each of the studies demonstrated the need for
further research regarding AHA guidelines in all aspects. Future research should focus on
all the different elements of the AHA guidelines, such as incorporating the blood pressure
classification range, lifestyle modifications, correct therapy, and follow-up appointment.
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In addition, the majority of the primary care providers were non-compliant in
implementing the 2017 AHA Hypertension Guidelines during this study. Therefore,
future studies should focus on the determining reasoning of non-compliance among
primary care providers in regard to implementing 2017 AHA Hypertension Guidelines.
Also, another area of researcher could include measures to prompt primary care providers
awareness in the electronic charting system of the patients with elevated blood pressure
readings during the visit.
Numerous limitations were identified in this study. These limitations decreased
the accuracy and representation of the findings and collected data. The data were
collected from four primary care clinics in a relatively small geographic area of the
southeastern United States; therefore, this study is not representative of a vast population.
A larger sample size could be obtained by collecting data in multiple states throughout
various regions, which will yield a national representation of primary care providers'
implementation of the 2017 AHA Hypertension Guidelines.
Another limitation of this study was the documentation of various lifestyle
modifications by primary care providers. The 2017 AHA Hypertension Guidelines
recommended initiation of nonpharmacological treatment when the patient's blood
pressure was considered elevated. Non-pharmacological treatment, according to 2017
AHA Hypertension Guidelines, includes weight loss, diet recommendation, potassium
supplementation, exercise, limit alcohol, and smoking cessation. During the chart review,
the researchers realized that most primary care providers documented 1-2 therapies, but
not all of them. For example, some primary care providers may consider diet
recommendations and exercise as weight-loss counseling; therefore, there was no need to
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document all three therapies. This flaw could have possibly limited the findings of this
study.
Another limitation identified in this study was the primary care provider
documentation of smoking cessation as an optimal lifestyle habit. The 2017 AHA
Hypertension Guidelines do include smoking cessation as an optimal lifestyle habit,
however, the research data tool created by the researchers did not include questioning
regarding smoking status, therefore, if the patient was not a smoker, the primary care
provider will not have the reasoning to document smoking cessation counseling. With the
non-pharmacological therapy of smoking cessation included in the AHA Hypertension
guidelines, it was important for the researchers to obtain the patient's smoking status.
This aspect potentially decreased the percentage of primary care providers implementing
smoking cessation education for elevated blood pressure and could have skewed the
results of this study.
Two limitations were identified within the research tool questionnaire created by
the researchers. Question number nine stated, “If yes, was any of the following
recommended nonpharmacological treatment documented?” Then continues to list the
nonpharmacological therapies but does not include the option “No.” Question number 10
stated, “Was a follow-up appointment documented within 3-6 months for reevaluation? If
not, was a follow-up appointment made within 12 months regarding elevated blood
pressure?” Question number 10 included two questions, which should have been
separated individually to collect accurate data. With these two defects noted within the
Research Tool questionnaire, the collected data can be skewed.

61
Some limitations noted were specific to the clinical site that the researchers
utilized for chart reviews that could have possibly altered the research collected data. For
example, one of the four clinics did not have documented ethnicity for patients; therefore,
skewing the demographics data. In addition, another clinic primary care provider offered
weight-loss counseling and Phentermine (Adipex-P), which requires a handwritten
prescription every three months. Therefore, a patient with elevated blood pressure or
obesity could be recommended for weight loss, diet recommendation, exercise, and a
three-month follow-up, but cannot distinguish if the follow-up was for elevated blood
pressure or weight loss management. Finally, some of the clinics had frequent acute care
visits with patients with elevated blood pressure; therefore, no scheduled follow-up visit
was documented because the patient was aware of the condition and only visited the
clinic to manage acute conditions. This incidence could have altered the results of followup data collected.
The most significant limitation observed within this study is the Covid Pandemic.
Many possible alterations could have concluded from the effects of the Covid pandemic.
The first effect is the required decreased number of non-staff individuals within the clinic
to incorporate social distance practices, limiting patient appointment visits per day.
Therefore, reducing the availability of chart reviews dated from the start of the pandemic
in March 2020. Another impact is decreased patient follow-up visits to limit potential
exposure to Covid; therefore, medications were refilled without follow-up appointments.
In addition, the younger population were more likely to arrive for face-to-face visits
rather than the elderly due to the increased fatal complications and risk of covid within
the elderly population. Another limitation is telehealth visits within clinics to prevent
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possible exposure, which reduces the chance of the patient having a documented blood
pressure obtained during the visit. Therefore, many patient charts could not be included
in the sample because telehealth visits did not include documented blood pressures.
Implications
Approximately 1.13 billion people around the world have a confirmed diagnosis
of hypertension (WHO, 2019). According to the Mississippi Department of Health, more
than 700,000 adults have a diagnosis of hypertension (Mississippi State Department of
Health, 2019). The rates of hypertension in Mississippi are among the top in the country.
Hypertension places patients at an increased risk of heart disease and stroke. In 2017, the
American Heart Association (AHA) released guidelines to aid providers in the early
detection and management of hypertension. These guidelines integrate
nonpharmacological and pharmacological treatments. The nonpharmacological therapies
that can be utilized to prevent hypertension include following a heart-healthy diet, weight
loss, sodium restriction, limitation of alcohol and tobacco consumption, and increased
physical activity (2018). These modifiable factors can also reduce the risk of strokes,
with the addition of adequately managing elevated blood pressures.
This study was intended to determine if primary care providers are adhering to the
2017 AHA Hypertension Guidelines in regards to managing, educating and following up
with those patients with a documented elevated blood pressure. If the study’s findings
indicate that patients with elevated blood pressure are not being treated according to the
guidelines, then further research could be conducted analyzing the primary care providers
compliance. If patients with elevated blood pressure are not being managed, educated,
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and followed up with as recommended by AHA guidelines, then this study will indicate
that education is needed for the clinics in this study as well as other primary care clinics,
providers, and nurses in similar areas.
Recommendations
Recommendations for this study primarily include correction of the limitations.
For future research, increasing the sample size and expanding the geographical area
would provide a better representative of a vast population. This study was limited to
small, rural clinics due to the Covid pandemic. A larger sample size in different
geographic areas would give a better insight regarding primacy care providers adherence
to the 2017 AHA Hypertension Guidelines. Another recommendation is using an in-depth
research tool to document the data that has been validated in previous research. The
research tool used in the current study was constructed by the student researchers. The
information was generalized and was not all inclusive of the treatments included in the
guidelines. According to 2017 AHA Hypertension guidelines, non-pharmacological
therapy includes weight loss, diet recommendation, potassium supplementation, exercise,
and limit alcohol. This study only listed weight loss and diet recommendations on the
research tool. Further recommendations include a focus on education. Primary care
providers should be educated on all aspects of the 2017 AHA Hypertension Guidelines,
including where to locate the guidelines, how to use them, and the ramifications if the
guidelines are not followed. Primary care providers, currently practicing, should stay up
to date on the latest guidelines by reading evidence-based practice articles and attending
continuing education conferences. The last recommendation for future research would be
to allow more time to complete the study. The limited time used in this study may have
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limited the sample size. By providing additional research time to complete the study, a
greater variety of patients would allow the study to provide more accurate results.
Conclusions
This was a retrospective chart review study that determined if primary care
providers are implementing the 2017 AHA Hypertension Guidelines in managing
elevated blood pressure as a modifiable risk factor of stroke. The study revealed that
primary care providers were not implementing the 2017 AHA Hypertension Guidelines
regarding elevated blood pressure. Recent studies show if hypertension is controlled
early or if elevated blood pressure is managed and never advances to hypertension, the
risk of a cardiovascular event would be significantly reduced, thus reducing morbidity
and mortality. There are limitations to this study that can be corrected and improved for
future research studies. The findings that were revealed in this study indicate diligence is
needed by primary care providers regarding implementation of the 2017 AHA
Hypertension Guidelines. Primary care providers know firsthand, the long-term effect of
hypertension on the cardiac system. Further research should be conducted to determine
why providers are not adhering to the updated guidelines.
The primary focus of the study was to evaluate the implementation of the 2017
AHA Hypertension Guidelines. With the overwhelming evidence that elevated blood
pressure leads to cardiovascular events and mortality, primary care providers must be
knowledgeable and implement the guidelines to prevent significant morbidity and
mortality with Mississippi being in the top five states for cardiovascular disease. Stokes
are among the top leading causes of death in the United States. The rates of hypertension
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in Mississippi are among the top in the country. It is imperative that primary care
providers are not only knowledgeable, but also aggressive when managing elevated blood
pressure.
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APPENDIX A
DATA COLLECTION RESEARCH TOOL
1. Age:
18-44 _____
45+ _____
2. Gender:
Male _____
Female _____
Other _____
3. Race:
African American _____
Caucasian _____
Hispanic _____
Asian _____
Other _____
4. Provider type:
Nurse Practitioner ____
Physician ____
Physician Assistant _____
5. Does the patient have a documented past medical history of hypertension? If yes,
patient will be excluded. If no, proceed to next question.
Yes ____
No ____
6. Payor source:
Medicare/Medicaid _____
Commercial _____
Private Pay _____
Self-Pay _____
None _____
7. Were vital signs obtained during the visit?
Yes ____
No ____
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8. Did the patient have a documented elevated blood pressure of 120-129/ <80?
Yes ____
No ____
9. If yes, was any of the following recommended nonpharmacological treatment
documented?
Weight loss, if overweight or obese _____
Diet recommendations _____
Potassium supplementation _____
Exercise _____
Limit alcohol consumption _____
Smoking cessation _____
10. Was a follow up appointment documented within 3-6 months for reevaluation? If not,
was a follow up appointment made within 12 months regarding elevated blood
pressure?
Yes _____
No _____
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APPENDIX B
IRB Approval of Mississippi University for Women
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APPENDIX C
Consent to Conduct Study
To Whom It May Concern:
SUBJECT: Permission to participate in a research project
We are graduate students in the family nurse practitioner program at Mississippi
University for Women in Columbus, Mississippi. As a part of our nursing research
project, we are conducting a retrospective chart review to determine if primary care
providers are following up with patients within 3-6 months to monitor elevated blood
pressure according to the 2017 AHA hypertension guidelines. We will also verify that
patients are educated on nonpharmacologic therapies to better manage elevated blood
pressure. The students that will be participating in this project are Chelsi Archie, Chelsea
Bullock, Nekesha Johnson, and Elizabeth Lishman.
Your participation will involve granting us the privilege of reviewing 100 charts
from your primary care clinic. The target population for the study will include patients,
18 years or older, without a confirmed diagnosis of hypertension and who reside in the
Southeastern United States. Data collected will remain confidential and will not contain
any patient or provider identifying information. Data will be collected on a research tool
then entered into a computer spreadsheet and stored on a flash drive that will only be
accessible to researchers involved in the study. A completed copy of the research project
will be provided to the clinic for possible use in a performance improvement project. The
lead investigator’s contact information has been provided at the end of the participant’s
informative letter.
If you require any additional information about this study or would like to speak
to one of the researchers, please call Chelsi Archie (601) 750-4720, Chelsea Bullock
(731) 607-8281, Nekesha Johnson (662) 809-2309, and Elizabeth Lishman (662)3476017. You may also contact the chair of our research committee, Dr. Sueanne Davidson,
DNP, APRN, FNP-BC at (205)339-1433. In addition, you may withdraw your consent
and participation in this study at any time by contacting one of us or the chair of our
research committee.
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Sincerely,
Chelsi Archie, RN, BSN, FNP Graduate Student
Chelsea Bullock, RN, BSN, FNP Graduate Student
Nekesha Johnson, RN, BSN, FNP Graduate Student
Elizabeth Lishman, RN, BSN, FNP Graduate Student
I have read the above letter of consent and agree to the utilization of this clinic for the
above-mentioned research project. I also understand that the results of the study will be
made available to me at the project’s end.
________________________________________________________________________
Name, Title, Signature, Date

